Fresenius Kabi is a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Our product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the medical devices for administering these products. Within transfusion technologies, Fresenius Kabi offers products for whole blood and blood components collection and processing as well as for transfusion medicine and cell therapies.

With its Headquarters in Germany, Fresenius Kabi has around 32,500 employees worldwide and a global network of 65 sales organizations, 74 production sites and compounding centers, and 16 R&D centers. In 2014, Fresenius Kabi’s sales were €5,145 million and the company’s EBIT was €873 million.

Fresenius Kabi has been active in Asia Pacific for more than 30 years. The company is operating subsidiaries in 13 countries, running 16 production sites and compounding centers as well as 3 research and development centers.

In 2013, we started a branding initiative to build a strong Fresenius Kabi brand worldwide and as part of this initiaive we redefined the existing company values.

Customer Focus

Quality

Integrity

Collaboration

Creativity

Pasison & Commitment  

Clinical Nutrition: It covers parenteral and enteral nutrition. The PN group is including Multi-Chamber Bags, Lipids and  Additives Amino Acids; The EN group is including Oral Nutritional   Supplements and Tube Feeds Medical Devices and the products are mainly used in Intensive Care Units, General Wards, Nursing Homes Outpatients with the therapeutic areas in  Critical Illness, Oncology, Liver Insufficiency, Renal Insufficiency, Diabetes Mellitus, Maldigestion/ Malabsorption.

I.V. Drugs: It covers Oncology Drugs, Anesthetics & Analgesics, Antibiotics, Critical Care Drugs and Infusion Therapy. Infusion Management Systems and are mainly used in Emergency Medicine, Surgery Intensive Care and General Wards.

Infusion Therapy: It covers Pharmaceuticals administered via the vein. The products are including Infusion Solutions, Colloids for Blood Volume Replacement Therapy, Medical Devices for Applications and Pump Systems with the the therapeutic area in Blood Volume Substitution and Fluid Management.

Medical Devices: It covers Automated Blood Technology and Whole Blood Technology. The products are including Amicus, Alyx, Aurora, CompoMat G5, CompoDock, Blood Bag System, CompoLab T5, CompoGuard and C.A.T.S.